NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: WBD) between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 24, 2025. SO WHAT: If you purchased WBD securities during ...

NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Match Group, Inc. (NASDAQ: MTCH) between May 2, 2023 and November 6, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 24, 2025 in the securities class action first filed by the Firm. SO WHAT: If you ...

文章核心观点 - 罗森律师事务所提醒在2024年6月11日至2024年11月3日期间购买Lilium N.V.证券的投资者注意2025年1月6日的首席原告截止日期 [1] - 如果投资者在上述期间购买了Lilium证券，可能有权通过胜诉收费安排获得赔偿，无需支付任何费用 [2] 行动指南 - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=30744或联系Phillip Kim律师加入Lilium集体诉讼 [3] - 投资者可以选择自己的律师，也可以选择不采取任何行动，但这不会影响其分享未来可能的赔偿的权利 [7] 罗森律师事务所的优势 - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面有丰富的经验，曾创下中国公司证券集体诉讼的最大和解记录 [4] - 该律所自2013年以来每年都位列前四，并在2017年被评为证券集体诉讼和解数量第一 [4] - 2019年，该律所为投资者追回了超过4.38亿美元 [4] 案件详情 - 诉讼指控Lilium在集体诉讼期间发布了虚假和误导性声明，包括夸大融资活动的进展、夸大获得足够资金继续运营的可能性、未能充分披露Lilium及其子公司的即将破产风险 [5] - 这些行为导致Lilium的正面声明关于其业务、运营和前景的声明具有误导性 [5]

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025. SO WHAT: If you purchased Dentsply common stock duri ...

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Toronto-Dominion Bank (NYSE: TD) between February 29, 2024 and October 9, 2024, both dates inclusive (the “Class Period”), of the important December 23, 2024 lead plaintiff deadline. SO WHAT: If you purchased TD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Zeta Global Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2025. SO WHAT: If you purchased Zeta securities during ...

文章核心观点 - 罗森律师事务所提醒在2024年5月10日至2024年10月17日期间购买Humacyte, Inc. (NASDAQ: HUMA)证券的投资者注意2025年1月17日的首席原告截止日期 如果投资者在此期间购买了Humacyte证券，可能有权获得赔偿，无需支付任何费用或成本 投资者可以通过罗森律师事务所加入集体诉讼 [1][2] 行动指南 - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=31305或致电Phillip Kim, Esq. (866-767-3653)或发送电子邮件至case@rosenlegal.com加入Humacyte集体诉讼 已经有一项集体诉讼被提起 如果希望担任首席原告，必须在2025年1月17日之前向法院提出动议 首席原告是代表其他集体成员指导诉讼的代表方 [2] 罗森律师事务所的优势 - 罗森律师事务所鼓励投资者选择具有成功领导角色记录的合格律师 许多发出通知的律师事务所没有类似的经验、资源或任何有意义的同行认可 许多这些律师事务所实际上并不诉讼证券集体诉讼，而只是中间人，将客户或与实际诉讼案件的律师事务所合作 罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼 罗森律师事务所在当时实现了对中国公司最大的证券集体诉讼和解 罗森律师事务所在2017年ISS证券集体诉讼服务排名中名列第一 自2013年以来，该律师事务所每年都排名前四，并已为投资者追回了数亿美元 仅在2019年，该律师事务所就为投资者追回了超过4.38亿美元 2020年，创始合伙人Laurence Rosen被law360评为原告酒吧的泰坦 该律师事务所的许多律师已被Lawdragon和Super Lawyers认可 [3] 案件详情 - 根据诉讼，在集体诉讼期间，被告做出了虚假和/或误导性的陈述，和/或未能披露以下内容：(1) Humacyte的Durham, North Carolina设施未能遵守良好的制造实践，包括质量保证和微生物测试 (2) 由于Humacyte纠正这些缺陷，FDA对生物制品许可证申请(BLA)的审查将被推迟 (3) 因此，FDA批准无细胞组织工程血管(ATEV)用于血管创伤存在重大风险 (4) 因此，被告关于Humacyte的业务、运营和前景的积极陈述在实质上是误导性的，或缺乏合理依据 当真实细节进入市场时，诉讼声称投资者遭受了损失 [4]

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TMC the metals company Inc. (NASDAQ: TMC) between May 12, 2023 and March 25, 2024, both dates inclusive (the “Class Period”), of the important January 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased TMC securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

文章核心观点 - 罗森律师事务所宣布代表在2024年1月25日至2024年10月28日期间购买了Xerox Holdings Corporation（纳斯达克代码：XRX）证券的投资者提起集体诉讼 [1] 诉讼详情 - 诉讼指控Xerox在集体诉讼期间发布了虚假和/或误导性的声明，未能披露以下事实： - 在大幅裁员后，Xerox的销售团队进行了重组，包括新的区域分配和账户覆盖 [5] - 这导致Xerox的销售团队生产力受到干扰 [5] - 因此，Xerox的旧产品销售率下降 [5] - 清理旧产品的困难将推迟关键产品的发布 [5] - 因此，Xerox的销售和收入可能会下降 [5] - 这些因素导致Xerox关于其业务、运营和前景的正面声明具有误导性或缺乏合理依据 [5] 投资者行动 - 在集体诉讼期间购买Xerox证券的投资者可能有权获得赔偿，无需支付任何费用或成本 [2] - 投资者可以通过访问https://rosenlegal.com/submit-form/?case_id=31433或联系Phillip Kim律师（电话：866-767-3653，邮箱：case@rosenlegal.com）加入Xerox集体诉讼 [3][6] - 投资者可以选择自己的律师，也可以选择不采取任何行动，作为缺席的集体成员 [7] 罗森律师事务所介绍 - 罗森律师事务所鼓励投资者选择具有成功领导经验的合格律师 [4] - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面有丰富的经验，并在2017年ISS证券集体诉讼服务排名中名列第一 [4] - 罗森律师事务所的律师多次被Lawdragon和Super Lawyers认可 [4]

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 17, 2025. SO WHAT: If you purchased Humacyte securities during the Class P ...